"Guidant Corp.'s stock price sank 3 percent Monday as investor questions rose over the medical device maker's defibrillator recall and its impact on the pending takeover by Johnson & Johnson.
"Guidant's share price fell $2.16, to $70.30, its lowest price since the Indianapolis company agreed on Dec. 15 to be acquired by Johnson & Johnson." [Indystar.com]
